Therapeutic invariant natural killer T cells
Term · Oncology and biomedicine · MLC-T-ONC-017130
A preparation of natural killer T cells (NKTs) expressing an invariant (alpha, beta) T-cell receptor (iNKTs), with potential immunomodulating and antineoplastic activities. Upon infusion of the therapeutic iNKTs, these cells recognize CD1d-restricted lipid ligands, which are expressed on certain tumor cells, and secrete large amounts of various cytokines. This may activate the immune system against tumor cells. Additionally, iNKTs directly target and lyse tumor cells.
| Identifier | MLC-T-ONC-017130 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | therapeutic iNKT; therapeutic iNK T cells; therapeutic iNKT cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017130",
"term": "Therapeutic invariant natural killer T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of natural killer T cells (NKTs) expressing an invariant (alpha, beta) T-cell receptor (iNKTs), with potential immunomodulating and antineoplastic activities. Upon infusion of the therapeutic iNKTs, these cells recognize CD1d-restricted lipid ligands, which are expressed on certain tumor cells, and secrete large amounts of various cytokines. This may activate the immune system against tumor cells. Additionally, iNKTs directly target and lyse tumor cells.",
"synonyms": [
"therapeutic iNKT",
"therapeutic iNK T cells",
"therapeutic iNKT cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/therapeutic-invariant-natural-killer-t-cells/"
}
Record 16,256 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.